| David Mersy, MD | |
|
12000 Elm Creek Blvd N, Maple Grove, MN 55369-7074 | |
| (763) 420-7048 | |
| (763) 420-7938 |
| Full Name | David Mersy |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 12000 Elm Creek Blvd N, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588618870 | NPI | - | NPPES |
| 1004619 | Other | MN | PREFERRED ONE |
| 403L1ME | Other | MN | BLUE CROSS BLUE SHIELD |
| 6607902 | Other | MN | MEDICA CHOICE |
| HP13966 | Other | MN | HEALTHPARTNERS |
| 125487 | Other | MN | UCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 18735 (Minnesota) | Primary |
| Entity Name | Northwest Allied Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003833179 PECOS PAC ID: 7618972514 Enrollment ID: O20060928000110 |
News Archive
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
In a recent study, researchers developed and validated a nanoimmunoassay (NIA) that analyzes 1,024 samples in parallel on a single microfluidic device the size of a USB stick. They detected anti-SARS-CoV-2 IgG antibodies, achieving a sensitivity of 98% and specificity of 100% based on an analysis of 134 pre-pandemic sera (collected in 2013/2014 and 2018) and 155 sera from reverse transcription-polymerase chain reaction (RT-PCR) positive individuals.
Focusing on looming Medicare physician cuts of 21 percent that begin on March 1, the American Medical Association (AMA), AARP and the Military Officers Association of America (MOAA) joined together today in an unprecedented multi-state event.
Discovery of a new drug with high potential to treat Ewing sarcoma, an often deadly cancer of children and young adults, and the previously unknown mechanism behind it, come hand-in-hand in a new study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah. The report appears in today's online issue of the journal Oncogene.
Wilshire Oncology Medical Group, Inc., a physician-owned, multi-specialty cancer and blood disease practice in Southern California, and US Oncology, Inc., the nation's leading integrated oncology company, today announced a new collaboration in Southern California to expand patient access to high-quality, advanced cancer care through the United Network of US Oncology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Mersy, MD 16090 Andrie St Nw, Ramsey, MN 55303-3871 Ph: (763) 274-2808 | David Mersy, MD 12000 Elm Creek Blvd N, Maple Grove, MN 55369-7074 Ph: (763) 420-7048 |
News Archive
Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective. Slightly too much and it becomes toxic," explains Professor Pablo Sinues.
In a recent study, researchers developed and validated a nanoimmunoassay (NIA) that analyzes 1,024 samples in parallel on a single microfluidic device the size of a USB stick. They detected anti-SARS-CoV-2 IgG antibodies, achieving a sensitivity of 98% and specificity of 100% based on an analysis of 134 pre-pandemic sera (collected in 2013/2014 and 2018) and 155 sera from reverse transcription-polymerase chain reaction (RT-PCR) positive individuals.
Focusing on looming Medicare physician cuts of 21 percent that begin on March 1, the American Medical Association (AMA), AARP and the Military Officers Association of America (MOAA) joined together today in an unprecedented multi-state event.
Discovery of a new drug with high potential to treat Ewing sarcoma, an often deadly cancer of children and young adults, and the previously unknown mechanism behind it, come hand-in-hand in a new study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah. The report appears in today's online issue of the journal Oncogene.
Wilshire Oncology Medical Group, Inc., a physician-owned, multi-specialty cancer and blood disease practice in Southern California, and US Oncology, Inc., the nation's leading integrated oncology company, today announced a new collaboration in Southern California to expand patient access to high-quality, advanced cancer care through the United Network of US Oncology.
› Verified 2 days ago
Dr. Pamela D Doorenbos, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 9825 Hospital Dr, Suite 300, Maple Grove, MN 55369 Phone: 763-494-7500 Fax: 763-494-7501 | |
Keith Johnson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9855 Hospital Dr Ste 102, Maple Grove, MN 55369 Phone: 763-581-5900 Fax: 763-581-5901 | |
Dr. Mark S Hench, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9855 Hospital Dr, Ste 102a, Maple Grove, MN 55369 Phone: 763-581-9220 | |
Mirtha Nesheim, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12000 Elm Creek Blvd N, Maple Grove, MN 55369 Phone: 763-420-5822 Fax: 763-420-6387 | |
Ronald B Boeding, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9645 Grove Cir N Ste 200, Maple Grove, MN 55369 Phone: 763-201-8191 Fax: 763-201-8192 | |
Moushumi Meher, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9825 Hospital Dr Ste 300, Maple Grove, MN 55369 Phone: 763-587-7900 Fax: 763-494-7501 | |
Pamela Kolacz, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6320 Wedgwood Rd N, Maple Grove, MN 55311 Phone: 763-268-0400 Fax: 763-268-0405 |